Endocyte Inc
(ECYT)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2009 | 12-2008 | |
| Assets | ||
| Current Assets | ||
| Cash & Cash Equivalents | 8,690 | 0 |
| Marketable Securities | 15,210 | 0 |
| Other current assets | 380 | 0 |
| TOTAL | $24,280 | $0 |
| Non-Current Assets | ||
| PPE Net | 2,970 | N/A |
| Other Non-Current Assets | 60 | 0 |
| TOTAL | $3,030 | $N/A |
| Total Assets | $25,260 | $0 |
| Liabilities | ||
| Current Liabilities | ||
| Short Term Debt | 6,250 | 0 |
| Accounts payable and accrued liabilities | 1,780 | 0 |
| Accrued Expenses | 530 | 0 |
| Other current liabilities | 220 | 0 |
| TOTAL | $8,800 | $0 |
| Non-Current Liabilities | ||
| Long Term Debt | 2,710 | 0 |
| Other Non-Current Liabilities | 89,790 | 0 |
| TOTAL | $92,500 | $N/A |
| Total Liabilities | $101,320 | $0 |
| Shareholders' Equity | ||
| Common Shares | 1,910 | 0 |
| Retained earnings | -77,970 | 0 |
| Other shareholders' equity | 10 | 0 |
| TOTAL | $-76,050 | $0 |
| Total Liabilities And Equity | $25,270 | $0 |